Showing posts with label economy. Show all posts
Showing posts with label economy. Show all posts

Thursday, October 17, 2013

Give me your innovators yearning to breathe free

by Bernard Munos, FasterCures Senior Fellow


Ingenuity defines America. From sea to shining sea, the country bristles with innovation. Google, eBay, Intel, Tesla, Yahoo, SpaceX, LinkedIn, Flickr, Facebook, exemplify the indomitable American genius… or perhaps the indomitable genius of its immigrants, as all these companies were (co-) founded by foreign-born entrepreneurs.
This is no artifact. Economic geography shows that innovation thrives where cultures blend. It is true of countries built by immigrants, such as the United States, Australia, or Israel. It is also clear from the capitals of former European empires – Berlin, Vienna/Budapest, Paris, London – where the mingling of ethnicities created the ferment that transformed them into cosmopolitan beacons of artistic and technological power. Further back in history, Florence, Venice, Rome, Athens, Constantinople, and Alexandria have all at some point leveraged their positions on trading routes, or their dominion over faraway provinces, to create the cultures that gave us the Renaissance, Hellenism, and the Islamic golden age – when roving scholars from Cordoba to Bukhara made major contributions to medicine, mathematics, and astronomy. 
Today, innovation continues to thrive where cultures overlap: Silicon Valley, Boston, Quebec, Singapore, the Baltic Rim, Switzerland, Flanders, and many other regions.  In the United States, the foreign-born represent 12% of the population, but they account for 25% of its Nobel prizes, 25% of the founders of venture-backed companies,30% of its patents SaveFrom.net, and 47% of its scientists and engineers with doctorate degrees. Immigrants are over-represented among members of the National Academy of Sciences and the National Academy of Engineering, and among the authors of highly-cited science and engineering journal articles.
It is as if innovation somehow comes more naturally to people who internalize various cultures. Research and casual observation actually support that idea. Polyglots know, for instance, that one does not think alike in various languages. A Frenchman does not think like a German. One is holistic, the other is methodical. These differences carry over to how we solve problems. Some cultures are analytic and reductionist, others are intuitive and associative. No single approach is better, but, depending upon the problem, some may be more appropriate. People steeped in multiple cultures can access a broader set of problem-solving pathways and pick one that best fits the situation at hand.
There are other reasons that put immigrants at an advantage when it comes to innovation. They are apt at challenging norms and authority, and prone to act when unhappy with their lot. With their accents and customs, they never quite fit in, and are used to being different and operating from the margin. They are also at ease with disruption, which is part and parcel of being an immigrant. Like entrepreneurs, they have a tolerance for risk, and a bias for action.  And they top that with a relentless drive to succeed because they can never be completely mainstream.
Research also shows that immigrants have an uncanny ability to function in multiple worlds at the same time. They often grow up speaking one language at home and a different one at school, and they sometimes must learn several languages as their parents change countries to flee war or persecution. Those who become scientists retain the agility to move back and forth between multiple domains. They are boundary crossers, with interest and expertise in multiple disciplines, but operating preferably at their interface. They are not biologists or chemists or physicists, they straddle the boundaries between these sciences, and can see connections that might elude less versatile scientists. This makes them especially effective problem-solvers. They think differently, can approach problems from various angles, and harness multiple problem-solving tools.
With such attributes, one would think that countries blessed with immigrants would see them as assets to be leveraged, not a ball and chain on the economy. Indeed, those that value them, such as Israel, are among the world’s most innovative societies.  But most nations see immigrants unfavorably, like welfare collectors, and relegate them to camps and ghettos. It does not help that many have a precarious immigration status – like temporary visas that get overstayed or no visa at all. But then, people who flee war and misery seldom have their papers in order. This makes much of the current US debate on immigrants – and whether they arrived legally – a bit disingenuous. We should do what best serves the interests of America, and not lose ourselves in legalistic arguments.  Immigration is like free-trade. It benefits a country, even if the other party does not play fair. Just as a nation gains from engaging in free-trade, even if its partners do not reciprocate, it also gains from welcoming immigrants, however they arrived. This is not a plea to lift all restrictions, but one to manage them wisely.
Immigrants build great nations, but as societies mature, they tend to lose their vitality. They become risk-averse while entrenched interests and bureaucracy combine to enshrine the status quo into complex regulations that deter change and innovation. America has aged better than most, due in no small part to the fact that it remains by far the top destination for the migrants of the world, taking in roughly 20% of its “huddled masses yearning to breathe free”. This has been America’s enduring success formula: a multicultural society constantly refreshed by a flux of immigrants that accomplish here what they could have never done elsewhere. Immigration has given us many of our leading scholars and entrepreneurs, and the technological advances that have shaped our society and the world. Let’s make it easier for immigrants to continue to help us remain in the vanguard of innovation. No one else will.


Visit us on our new blog: www.fastercures.tumblr.com

Wednesday, February 13, 2013

Medical research delivers cures, saves lives and – oh, by the way – is pretty great for our economy too


Over the past few weeks, Washington D.C. has been abuzz with conversation about the value of medical research to our national economy, collective health, and global competitiveness. Leading up to our own Capitol Hill briefing with Friends of Cancer Research last Wednesday – “The Blueprint of Medical Research: How New Medicines Get from the Lab to the Patient” – FasterCures has attended several events focused on the impact of research and research funding on our nation’s well-being.

We’ve heard unequivocally that scientific opportunity – particularly when it comes to our understanding of disease biology – has never been greater, but the outlook for funding has also never been more worrisome.  If we don’t increase our investment in medical research, we’re effectively cutting it, risking not only a major engine that fuels our economy, but also the lives of hundreds of thousands of people living with diseases that have few or no meaningful treatment options.

The budgetary decisions we make today are decisions that won’t just have an impact in our lifetimes, but will alter the course of the next generation of patients, family members, and young scientists.  Here are some of the things we’ve heard around town: 
  • “If scientists can take a few minutes to put down their microscopes and pick up a microphone it will make a real difference.  As we stand at this budget crossroads, we need your help to make the case.”
    • Congressman Ed Markey (D-MA) at American Cancer Society’s Cancer Action Network briefing on Capitol Hill, February 5, 2013
  • “The FDA is really a bargain when you look at scope of activities that have exploded without parallel budget increases. FDA costs only about $8 per American per year, and we are determined to maximize the dollars that we have. Drugs are available in the U.S. faster than anywhere else in the world, and with 39 new approvals in 2012, including a number of new advances in personalized medicine, we are making real progress. Sequestration would result in a significant reduction of domestic and international inspections, which makes for a tough environment in which to recruit and retain top people. We cannot walk away from our responsibilities."
  • The average per capita National Institutes of Health investment is just under $100/citizen/year, and less than 1% of federal budget. Yet these investments are having an outsized impact on our economy and health. The more stories that scientists and patients can tell in their own words, the more likely it is that the message will resonate with our policymakers. 
  • “We have come so far in cancer science, especially in my field of immunotherapy. We now live in an age where it is possible to take the army in own bodies, and train it to fight against our particular disease. But scientists like me would not be where we are if not for the investments that were made in us at the start of our careers.  If the budget of the NIH is cut any further we will be faced with having to tell the patients who rely on our science: I’m sorry, there’s nothing more we can do.  No one wants to be the giver or receiver of this heartbreaking message.”
    • Helen Sabzevari, global head of oncology-immunotherapy for EMD Serono Inc. at American Cancer Society’s Cancer Action Network briefing on Capitol Hill, February 5, 2013
  • "The National Institutes of Health (NIH) supported more than 402,000 jobs and $57.8 billion in economic output nationwide in 2012 alone. If Congress fails to prevent the 5.1 percent automatic, across-the-board spending cuts slated for March 1, the nation's life sciences sector could lose 20,500 jobs and $3 billion in economic input."
Currently, only five cents of every U.S. health dollar goes to biomedical research; however, 1 in every 3 Americans is living with a deadly or debilitating disease for which there are no cures. The U.S. needs strong investment in biomedical research to deliver cures, save lives, and maintain our global competitiveness. There’s no time to waste.

Relevant links:
-- ACS CAN Report Highlights Critical Need for Sustained Funding for Cancer Research
-- Videocast of Jan. 14 SMRB meeting
-- The State of the FDA—February 2013
-- Report from United for Medical Research about the Economic Impact of Sequester on Life Sciences Sector
-- Sequestration Station
-- Time=Lives